Robin Farmanfarmaian

Business leader, Business mentor, Change agent, Entrepreneur, Investor, Philanthropist, Sales specialist, Single, Startup, Technologist

Robin Farmanfarmaian, an author, speaker, and entrepreneur, champions technology to empower patients and democratize healthcare. Her work educates the healthcare sector, large corporations, and individuals on leveraging AI and shifting care to the home. With over 200 keynotes in 15 countries, Farmanfarmaian has spoken for many of the key healthcare stakeholders, including UnitedHealthcare, Roche, P&G, Kaiser, BCBS, Verily, Abbott, The White House, the Medical Group Management Association, the American Academy of Dermatologists, NeuroNet, Takeda, and Boston Scientific. Currently she's the co-founder and CEO of FaciScribe, a generative AI company for use in the clinic. She's on an advisory board for multiple organizations, including: -ARPA-H, with $2.5B of grant funding for deep tech -iSono Health, a portable, AI-driven wearable ultrasound for breast cancer detection - Cyphr, a Venture Capital fund investing in transformational technology - Alacrity Care for in-home clinical trials for oncology - Luxsonic, VR for radiologists - ConceptVines, a VC fund and product engineering firm focused on disruptive tech Robin has written 4 books, including “The Patient as CEO: How Technology Empowers the Healthcare Consumer" (2015) and “How AI Can Democratize Healthcare: The Rise in Digital Care” (2022)

artificial intelligence, healthcare, medicine, Start Ups, technology